receptor Archives - Top Personal Health

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

April 13, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, antibody, cell, Coronavirus, Coronavirus Disease COVID-19, efficacy, enzyme, Nanoparticle, Nanoparticles, pandemic, pathogen, protein, receptor, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:, vaccine, virus

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Three emergent SARS-like diseases

Health News

New research could rescue failed immunotherapies for treating solid tumors

April 7, 2021 antibodies, antibody, breast cancer, cancer, cell, Immune Response, Immune System, Immunotherapy, medicine, Ovarian Cancer, protein, receptor, research, tumor

New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon

Health News

SARS-CoV-2 inhibits the cellular response to interferon

April 2, 2021 acute respiratory distress syndrome, cell, Coronavirus, Coronavirus Disease COVID-19, Cytokines, gene, genes, Immune Response, inflammation, Interleukin-6, lungs, Nucleic Acid, protein, receptor, respiratory, Retinoic Acid, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome:, virus

Severe coronavirus disease 2019 (COVID-19) is associated with the development of acute respiratory distress syndrome (ARDS), characterized by exacerbated inflammation

Health News

New research proposes innovative antibody-based treatment to prevent SARS-CoV-2 viral entry

March 17, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, antibody, cell, Coronavirus, Coronavirus Disease COVID-19, enzyme, protein, Pseudovirus, receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:

A brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy

Health News

Neanderthal gene can confer protection against severe COVID-19, finds study

February 22, 2021 Allele, cell, chromosome, Chromosome 12, Chromosome 3, Coronavirus, Coronavirus Disease COVID-19, DNA, frequency, gene, genes, Genetic, genome, Genomics, Infectious Diseases, Intensive Care, locus, Neanderthal, Phylogeny, receptor, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome:

Some of the genes in the human genome appear to confer a protective effect against severe coronavirus disease 2019 (COVID-19),

Health News

Cissampelos pareira L. extracts demonstrate anti-SARS-CoV-2 activity in vitro

February 22, 2021 cell, Coronavirus, Coronavirus Disease COVID-19, efficacy, Estrogen, fever, gene, genes, genome, hormone, in vitro, pathogen, protein, receptor, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Signaling Pathway, Spike Protein, syndrome:, virus

A team of scientists from India has recently investigated the antiviral potency of a traditional medicinal plant Cissampelos pareira L.

Health News

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

February 18, 2021 Antigen, cancer, cell, Chimeric Antigen Receptor, clinical trial, Follicular Lymphoma, hematology, Hodgkin Lymphoma, Lymphoma, medicine, Non-Hodgkin Lymphoma, Oncology, receptor, research, Transgene

A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five

Health News

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

February 16, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, antibody, Antigen, Blood, cell, Cell Membrane, Convalescent Plasma, Coronavirus, Coronavirus Disease COVID-19, Cytometry, enzyme, Flow Cytometry, genes, genome, Genome Editing, Germline, Glycoprotein, Immune Response, Immunoglobulin, pathogen, protein, receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome:, virus

The immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus

Health News

Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals

February 11, 2021 ACE2, antibodies, antibody, Antigen, cell, Coronavirus, Coronavirus Disease COVID-19, medicine, protein, receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:, vaccine

Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may

Health News

Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2

February 6, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, cell, Coronavirus, Coronavirus Disease COVID-19, Cysteine, dexamethasone, Drugs, efficacy, enzyme, Hydrogen Peroxide, in vitro, Mortality, oxygen, pandemic, pathogen, protein, Protein Expression, receptor, Renin, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:, virus, Zinc

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

← Previous